Among the 26 patients treated with IMGN901 anytime dose: – One patient had a partial response while receiving IMGN901. This patient continued the treatment for more than one year. – Three patients exhibited a minimal response during the reception IMGN901, and two of these patients remained in the treatment for at least 45 weeks. Typically patient withdrew from the study due to a broken leg while continuing to to show disease improvement.
– Eleven patients had stable disease , with eight of those patients who remained on treatment for at least 12 weeks at the time of data cut-off for presentation. These include four patients who have received at least 24 weeks and IMGN901 two other patients still under treatment. Often called ‘biosimilar ‘in Europe or ‘biogenerics ‘in the United States called- – Retacrit similar biological is to epoetin alfa.One study to the April edition of Journal of Parasitologie reports the first identification of of a sporozoite – specific protein that are of of forms of toxoplasma infections. Of this protein throws an antibody in Toxoplasma, the types of parasitic that. Causes toxoplasmosis protozoans The study was conducted by a team of scientists from different institutions that, of Dolores Hill and JP Dube the United States Department of Agriculture – Agricultural Research Service, Animal and Natural Resources Institute meat products Parasitic Diseases Laboratory in Beltsville, Md.,.
Toxoplasmosis, a shared parasitic infection, researchers is provided a special challenge because multiple paths of infection possible and date tests are not able distinguish between them.